申请人:Oikawa Nobuhiro
公开号:US20080119466A1
公开(公告)日:2008-05-22
The present invention provides a compound represented by the formula (1):
wherein
R
1
, R
2
and R
5
are each independently selected from a hydrogen atom, a halogen atom, a C
1
-C
6
alkyl is substituted with a halogen atom and the like;
R
3
and R
4
are each independently selected from a hydrogen atom, a halogen atom, a substituted C
1
-C
6
alkyl group and the like;
R
6
and R
7
are each independently selected from a hydrogen atom and a halogen atom;
Z
1
and Z
2
are each independently selected from a hydrogen atom, a hydroxyl group and —O(CHR
11
)OC(═O)R
12
;
Q is a group of the formula:
(wherein
G
1
is C—Y
2
or N;
a ring A is a benzene ring or a 5- to 6-membered unsaturated heterocycle)
a pharmaceutically acceptable salt thereof or a prodrug thereof.
本发明提供了一种由式(1)表示的化合物:其中,R1、R2和R5分别独立地选自氢原子、卤原子、C1-C6烷基被卤原子等取代基;R3和R4分别独立地选自氢原子、卤原子、取代的C1-C6烷基等基团;R6和R7分别独立地选自氢原子和卤原子;Z1和Z2分别独立地选自氢原子、羟基和—O(CHR11)OC(═O)R12;Q是下式的基团:(其中,G1是C—Y2或N;环A是苯环或5-至6-成员的不饱和杂环);其药学上可接受的盐或前药。